Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Birgit S Geurts

7PUBLICATIONS

65CO-AUTHORS

Cancer therapy (excl. chemotherapy and radiation therapy)Microbial ecologyMolecular targetsInnate immunityPredictive and prognostic markers

Featured researcher

Get your video featured.

Publish with JoVE

Featured researcher

Get your video featured.

Publish with JoVE

Publications (7)

Sort by Publication Date:

|Oct 01, 2025

Checkpoint Blockade Combinations in Tumor Mutational Burden/Load-High Tumors: Insights from the Atezolizumab + Bevacizumab and Nivolumab + Ipilimumab Cohorts in the Drug Rediscovery Protocol.

Karlijn Verkerk, Soemeya F Haj Mohammad, Laurien J Zeverijn

|Sep 25, 2025

Microbial Metabolic Pathways Guide Response to Immune Checkpoint Blockade Therapy.

Iris L Mimpen, Thomas W Battaglia, Miguel Parra-Martinez

|Oct 01, 2024

Safety, Efficacy, and Biomarker Analysis of Crizotinib in MET-Mutated Non-Small Cell Lung Cancer-Results from the Drug Rediscovery Protocol.

Karlijn Verkerk, Tijmen J W T van der Wel, Laurien J Zeverijn

|Jul 18, 2024

The Innate Immune Landscape of dMMR/MSI Cancers Predicts the Outcome of Nivolumab Treatment: Results from the Drug Rediscovery Protocol.

Laurien J Zeverijn, Birgit S Geurts, Thomas W Battaglia

|Jun 27, 2024

Maximizing Treatment Opportunities: Assessing Protocol Waivers' Impact on Safety and Outcome in the Drug Rediscovery Protocol.

Jade M van Berge Henegouwen, Laurien J Zeverijn, Birgit S Geurts

|May 15, 2024

Characterization of discordance between mismatch repair deficiency and microsatellite instability testing may prevent inappropriate treatment with immunotherapy.

Birgit S Geurts, Laurien J Zeverijn, Jade M van Berge Henegouwen

Pageof 2

Frequent Collaborators

7 joint publications

Laurien J Zeverijn

7 joint publications

Emile E Voest

7 joint publications

Hans Gelderblom

6 joint publications

Henk Mw Verheul

6 joint publications

Vincent van der Noort

5 joint publications

Louisa R Hoes

5 joint publications

Paul Roepman

5 joint publications

Anne Ml Jansen

4 joint publications

Jade M van Berge Henegouwen

4 joint publications

Hanneke van der Wijngaart

Frequent Collaborators

7 joint publications

Laurien J Zeverijn

7 joint publications

Emile E Voest

7 joint publications

Hans Gelderblom

6 joint publications

Henk Mw Verheul

Top Related Videos

Patient-Derived Tumor Explants As a "Live" Preclinical Platform for Predicting Drug Resistance in Patients

Patient-Derived Tumor Explants As a "Live" Preclinical Platform for Predicting Drug Resistance in Patients

Published on : Feb 07, 2021

Immunometabolic Circuits in Infection for Advancing Host Directed Therapies

Immunometabolic Circuits in Infection for Advancing Host Directed Therapies

Published on : Sep 13, 2024

Utilizing <sup>18</sup>F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer

Utilizing <sup>18</sup>F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer

Published on : Jul 21, 2018

See more related videos

Top Related Videos

Patient-Derived Tumor Explants As a "Live" Preclinical Platform for Predicting Drug Resistance in Patients

Patient-Derived Tumor Explants As a "Live" Preclinical Platform for Predicting Drug Resistance in Patients

Published on : Feb 07, 2021

Immunometabolic Circuits in Infection for Advancing Host Directed Therapies

Immunometabolic Circuits in Infection for Advancing Host Directed Therapies

Published on : Sep 13, 2024

Utilizing <sup>18</sup>F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer

Utilizing <sup>18</sup>F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer

Published on : Jul 21, 2018

See more related videos